Status:
COMPLETED
Invasive Fungal Infections Surveillance Initiative
Lead Sponsor:
University of Pittsburgh
Collaborating Sponsors:
Astellas Pharma US, Inc.
Conditions:
Fungal Infection
Eligibility:
All Genders
18+ years
Brief Summary
The purpose of this study is to optimize the management of patients treated for invasive fungal infections by establishing a real-time, continuous clinical data base that will capture and monitor tren...
Detailed Description
Gender, height, weight, ethnicity, antifungal treatment, fungal colonization, laboratory results, past medical history, invasive fungal infection diagnosis, medications, outcomes
Eligibility Criteria
Inclusion
- All patients with a diagnosis of proven or probable invasive fungal infection . This includes patients with proven or probable invasive mold infections as well as patients with proven candidemia.
Exclusion
- All patients with a diagnosis of possible invasive fungal infection . This includes patients with possible mold infections as well as patients with possible candidemia.
Key Trial Info
Start Date :
August 1 2005
Trial Type :
OBSERVATIONAL
Allocation :
ACTUAL
End Date :
August 1 2012
Estimated Enrollment :
172 Patients enrolled
Trial Details
Trial ID
NCT00177944
Start Date
August 1 2005
End Date
August 1 2012
Last Update
January 17 2013
Active Locations (1)
Enter a location and click search to find clinical trials sorted by distance.
1
University of Pittsburgh Medical Center
Pittsburgh, Pennsylvania, United States, 15213